Mimedx (MDXG) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.81% |
| Dec 31, 2025 | 32.85% |
| Sep 30, 2025 | 32.01% |
| Jun 30, 2025 | 28.91% |
| Mar 31, 2025 | 30.21% |
| Dec 31, 2024 | 35.31% |
| Sep 30, 2024 | 13,509.62% |
| Jun 30, 2024 | 1,426.70% |
| Mar 31, 2024 | 967.78% |
| Dec 31, 2023 | 893.40% |
| Sep 30, 2023 | 106.81% |
| Jun 30, 2023 | 6.89% |
| Mar 31, 2023 | -141.40% |
| Dec 31, 2022 | -22,036.59% |
| Sep 30, 2022 | -236.09% |
| Jun 30, 2022 | -90.60% |
| Mar 31, 2022 | 7.66% |
| Dec 31, 2021 | 154.67% |
| Sep 30, 2021 | -145.13% |
| Jun 30, 2021 | -131.22% |
| Mar 31, 2021 | -126.54% |
| Dec 31, 2020 | -100.44% |
| Sep 30, 2020 | -67.48% |
| Jun 30, 2020 | -7.39% |
| Mar 31, 2020 | -20.89% |
| Dec 31, 2019 | -30.73% |
| Sep 30, 2019 | -53.28% |
| Jun 30, 2019 | -69.58% |
| Mar 31, 2019 | -49.04% |
| Dec 31, 2018 | -32.71% |
| Sep 30, 2018 | -40.55% |
| Jun 30, 2018 | -44.90% |
| Mar 31, 2018 | -41.68% |
| Dec 31, 2017 | 53.53% |
| Sep 30, 2017 | 15.57% |
| Jun 30, 2017 | 21.11% |
| Mar 31, 2017 | 12.95% |
| Dec 31, 2016 | 38.43% |
| Sep 30, 2016 | 22.64% |
| Jun 30, 2016 | 30.42% |
| Mar 31, 2016 | 32.22% |
| Dec 31, 2015 | -61.13% |
| Sep 30, 2015 | 23.71% |
| Jun 30, 2015 | 25.17% |
| Mar 31, 2015 | 13.33% |
| Dec 31, 2014 | 21.42% |
| Sep 30, 2014 | 128.64% |
| Jun 30, 2014 | 126.47% |
| Mar 31, 2014 | 141.31% |
| Dec 31, 2013 | 267.71% |
| Sep 30, 2013 | 85.26% |
| Jun 30, 2013 | 109.92% |
| Mar 31, 2013 | 152.81% |
| Dec 31, 2012 | 68.15% |
| Sep 30, 2012 | 61.85% |
| Jun 30, 2012 | 21.22% |
| Dec 31, 2011 | 95.03% |